News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28,221 Results
Type
Article (1359)
Company Profile (5)
Press Release (26857)
Section
Business (14934)
Career Advice (68)
Deals (1940)
Drug Development (3275)
FDA (437)
Job Trends (575)
News (19524)
Policy (810)
Tag
Academia (32)
Allergies (5)
Alliances (1014)
ALS (5)
Alzheimer's disease (40)
Approvals (449)
Artificial intelligence (2)
Bankruptcy (3)
Best Places to Work (515)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (4)
Bladder cancer (5)
Brain cancer (2)
Breast cancer (8)
Cancer (82)
Cardiovascular disease (8)
Career advice (63)
CAR-T (3)
Cell therapy (6)
Cervical cancer (2)
Clinical research (2778)
Collaboration (7)
Compensation (9)
Complete response letters (1)
COVID-19 (68)
CRISPR (3)
C-suite (1)
Cystic fibrosis (4)
Data (89)
Diabetes (8)
Diagnostics (210)
Digital health (1)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (4)
Earnings (13566)
Editorial (1)
Events (2130)
Executive appointments (3)
FDA (510)
Frontotemporal dementia (1)
Funding (14)
Gene editing (4)
Gene therapy (6)
GLP-1 (20)
Government (80)
Guidances (46)
Healthcare (682)
IgA nephropathy (3)
Immunology and inflammation (1)
Indications (2)
Infectious disease (72)
Inflammatory bowel disease (1)
Intellectual property (1)
Interviews (9)
IPO (1467)
IRA (1)
Job creations (88)
Job search strategy (56)
Layoffs (10)
Legal (159)
Lung cancer (19)
Lymphoma (9)
Manufacturing (5)
MASH (4)
Medical device (662)
Medtech (662)
Mergers & acquisitions (481)
Metabolic disorders (19)
Multiple sclerosis (11)
NASH (2)
Neurodegenerative disease (3)
Neuroscience (68)
NextGen: Class of 2025 (141)
Non-profit (46)
Obesity (11)
Opinion (2)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (6)
Partnered (1)
Patents (3)
Patient recruitment (3)
Peanut (5)
People (835)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (693)
Phase II (1158)
Phase III (1027)
Pipeline (233)
Policy (2)
Postmarket research (231)
Preclinical (297)
Press Release (2)
Prostate cancer (1)
Radiopharmaceuticals (12)
Rare diseases (11)
Real estate (139)
Regulatory (614)
Reports (1)
Research institute (40)
Resumes & cover letters (3)
RSV (2)
Schizophrenia (4)
Series A (1)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (3)
Startups (72)
Supply chain (1)
Vaccines (9)
Venture capitalists (1)
Weight loss (4)
Women's health (1)
Date
Last 7 days (98)
Last 30 days (170)
Last 365 days (1553)
2025 (579)
2024 (1781)
2023 (2048)
2022 (2349)
2021 (2412)
2020 (2165)
2019 (1355)
2018 (1059)
2017 (846)
2016 (582)
2015 (834)
2014 (509)
2013 (301)
2012 (382)
2011 (474)
2010 (563)
Location
Africa (21)
Alabama (3)
Arizona (11)
Asia (1765)
Australia (217)
California (280)
Canada (86)
China (27)
Colorado (20)
Connecticut (15)
Delaware (12)
Europe (3444)
Florida (46)
Georgia (9)
Idaho (1)
Illinois (25)
India (1)
Indiana (20)
Japan (6)
Kansas (2)
Louisiana (3)
Maine (2)
Maryland (40)
Massachusetts (198)
Michigan (15)
Minnesota (25)
Missouri (2)
Montana (2)
Nevada (2)
New Hampshire (9)
New Jersey (98)
New York (97)
North Carolina (59)
Northern California (137)
Ohio (5)
Pennsylvania (94)
South America (33)
Southern California (117)
Tennessee (2)
Texas (32)
United States (1159)
Utah (20)
Virginia (1)
Washington D.C. (3)
Washington State (26)
Wisconsin (1)
28,221 Results for "107".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
U.S. Pharmaceutical Market Size to Hit USD 1,107.4 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Kelun-Biotech’s Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
March 26, 2025
·
3 min read
Press Releases
Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
May 8, 2025
·
10 min read
Press Releases
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
May 8, 2025
·
19 min read
Press Releases
Anova Announces First Patient Enrolled to Phase 1/2a Study of DB107 for the Treatment of High-Grade Gliomas
March 5, 2025
·
5 min read
Press Releases
DNA Sequencing Market Size Leads by 21.69% Healthy CAGR to Hit $107.63 Billion by 203
February 10, 2025
·
1 min read
Press Releases
Pharmaceutical Water Market Size to Soar from USD 42.26 Bn in 2024 to USD 107.15 Bn by 2034
February 13, 2025
·
1 min read
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Genetown
Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology , Displaying Ambifect ® Platform’s Versatility.
March 11, 2024
·
3 min read
BioMidwest
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
Anova Enterprises, Inc. has collaborated with University of California at San Francisco, University of California at San Diego, the University of Southern California and Denovo Biopharma to manage a newly awarded $11.8M California Institute for Regenerative Medicine grant to support the development of DB107 in patients with newly diagnosed high-grade glioma.
May 1, 2024
·
5 min read
1 of 2,823
Next
